Critical congenital heart disease (cCHD) has neurodevelopmental sequelae that can carry
into adulthood, which may be due to aberrant brain development or brain injury in the …

Abstract The National Heart, Lung, and Blood Institute convened a workshop in August 2021
to identify opportunities in pediatric and congenital cardiovascular research that would …

Aim To identify and map evidence describing components of neurodevelopmental follow‐up
care for children with congenital heart disease (CHD). Method This was a scoping review of …

Infants and children born with CHD are at significant risk for neurodevelopmental delays and
abnormalities. Individualised developmental care is widely recognised as best practice to …

Objective To evaluate brain biometry and cortical development by neurosonography in
fetuses with congenital heart defect (CHD) and evaluate differences among different type of …

Children with congenital heart disease (CHD) are at increased risk for neurodevelopmental
challenges across the lifespan. These are associated with neurological changes and …

Background Opioids are commonly used to provide analgesia during and after congenital
heart surgery. The effects of exposure to opioids on neurodevelopment in neonates and …

Introduction Infants with congenital heart disease (CHD) are at high risk for developmental
differences which can be explained by the cumulative effect of medical complications along …

Developmental disorders, disabilities, and delays are a common outcome for individuals
with complex congenital heart disease, yet targeting early factors influencing these …

Neurodevelopmental disability (NDD) is recognised as one of the most common
comorbidities in children with congenital heart disease (CHD) and is associated with altered …